HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Changing Beauty Retail Environment Leaves Indie Brands “Homeless”

This article was originally published in The Rose Sheet

Executive Summary

Niche brands are gravitating to upscale drugstore formats as specialty retail doors – including original “indie incubator” Sepora – close to them. Duane Reade’s “Look Boutique” has become one such refuge for homeless brands.

You may also be interested in...



L’Oreal Introduces Walgreens Shoppers To La Roche-Posay, Vichy Labs

L’Oreal casts a wider net for its La Roche-Posay and Vichy Laboratoires brands, at one time available exclusively in European pharmacies, expanding to select Walgreens locations across the U.S. Brands will be supported by interactive kiosk technology to educate consumers and enhance the shopping experience.

Elements Showcase Provides Launch Pad For Indie Scents

Unlike other trade shows where niche brands may be overshadowed by their larger peers, Elements celebrates the small guys. Its most recent installment in January 2012 attracted 110 brands and buyers from Barneys New York, Sephora, QVC and Saks Fifth Avenue, among other retailers, its founders say.

In Brief

To focus on its core beauty business, CVS/pharmacy will close all Beauty 360 locales May 19. P&G introduces CrestPro-Health Clinical to reduce plaque reoccurrence, while Philips Norelco launches new shavers that can be used wet or dry.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018164

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel